The AT1R blockade reduces glomerular afferent and efferent arteriolar resistances [28], but the extent to which AT1R blockade reduces the glomerular arteriolar resistances in sustained hypertension has not been completely studied. This evidence concerns the gene AGTR1 and hypertensive disorder.